Ovarian high-grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance.

MLA

Kido, Kansuke, et al. “Ovarian High-Grade Serous Carcinoma Cells with Low SMARCA4 Expression and High SMARCA2 Expression Contribute to Platinum Resistance.” The Journal of Pathology, vol. 260, no. 1, May 2023, pp. 56–70. EBSCOhost, https://doi.org/10.1002/path.6064.

APA

Kido, K., Nojima, S., Motooka, D., Nomura, Y., Kohara, M., Sato, K., Ohshima, K., Tahara, S., Kurashige, M., Umeda, D., Takashima, T., Kiyokawa, H., Ukon, K., Matsui, T., Okuzaki, D., & Morii, E. (2023). Ovarian high-grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance. The Journal of Pathology, 260(1), 56–70. https://doi.org/10.1002/path.6064

Chicago

Kido, Kansuke, Satoshi Nojima, Daisuke Motooka, Yusuke Nomura, Masaharu Kohara, Kazuaki Sato, Kenji Ohshima, et al. 2023. “Ovarian High-Grade Serous Carcinoma Cells with Low SMARCA4 Expression and High SMARCA2 Expression Contribute to Platinum Resistance.” The Journal of Pathology 260 (1): 56–70. doi:10.1002/path.6064.